Aragen Life Sciences CEO Manni Kantipudi wins 'CEO of the Year Award-2022
The award also highlights world-class technologies and solutions for medication development and clinical research
HYDERABAD: Manni Kantipudi, CEO of Aragen Life Sciences, a prominent R&D services outsourcing partner to global pharmaceutical businesses, was awarded 'CEO of the Year' at the CPHI Pharma Awards 2022 in Messe Frankfurt, Germany. Manni was honoured for his dynamic leadership, vision to build a sustainable organisation, and ability to guide the Aragen team toward a single objective by using their various talents and competencies.
The CPHI Pharma Awards honour the brightest individuals and companies, with winners chosen for their contributions to the field of pharma drug delivery and sustainable growth plans through product innovation. The award also highlights world-class technologies and solutions for medication development and clinical research.
Aragen has grown to be a global contract service provider for small molecules and biologics under Manni's leadership. It has continuously expanded its service portfolio, made strategic acquisitions in India and the United States, been certified by GPTW three times in a row, received a Silver rating for its sustainability initiatives from EcoVadis, and is a member of numerous global sustainability initiatives, including SBTi, PSIC, UNGC, and many others.
Manni Kantipudi was chosen from a shortlist of six candidates across the globe for demonstrating keen ability to engage staff and customers, while remaining committed to the development of the global contract research and manufacturing industry.